These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25356663)

  • 21. Testing superiority and non-inferiority hypotheses in active controlled clinical trials.
    Tsong Y; Zhang JJ
    Biom J; 2005 Feb; 47(1):62-74; discussion 99-107. PubMed ID: 16395997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Issues of simultaneous tests for noninferiority and superiority.
    Ng TH
    J Biopharm Stat; 2003 Nov; 13(4):629-39; discussion 641-62. PubMed ID: 14584713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of an equivalence acceptance criterion for accelerated stability studies.
    Burdick RK; Sidor L
    J Biopharm Stat; 2013; 23(4):730-43. PubMed ID: 23799811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of direct assay of an aqueous formulation of a drug compound AZY by chiral supercritical fluid chromatography (SFC).
    Mukherjee PS
    J Pharm Biomed Anal; 2007 Jan; 43(2):464-70. PubMed ID: 16930907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linearity evaluation of analytical methods that count particles.
    Magari RT; Rodriguez L
    Clin Chem Lab Med; 2004 Feb; 42(2):215-21. PubMed ID: 15061364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A fast ultra high pressure liquid chromatographic method for qualification and quantification of pharmaceutical combination preparations containing paracetamol, acetyl salicylic acid and/or antihistaminics.
    Deconinck E; Sacré PY; Baudewyns S; Courselle P; De Beer J
    J Pharm Biomed Anal; 2011 Sep; 56(2):200-9. PubMed ID: 21665401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statistical tools for setting in-process acceptance criteria.
    Seely RJ; Munyakazi L; Haury J
    Dev Biol (Basel); 2003; 113():17-25. PubMed ID: 14620848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfer of analytical procedures: a panel of strategies selected for risk management, with emphasis on an integrated equivalence-based comparative testing approach.
    Agut C; Caron A; Giordano C; Hoffman D; Ségalini A
    J Pharm Biomed Anal; 2011 Sep; 56(2):293-303. PubMed ID: 21700410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple comparisons of repeated measured response: issues of assessment of prolongation of QT interval in thorough QT trials.
    Tsong Y; Zhong J
    J Biopharm Stat; 2010 May; 20(3):604-14. PubMed ID: 20358439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sample sizes for batch acceptance from single- and multistage designs using two-sided normal tolerance intervals with specified content.
    Hauck WW; Shaikh R
    J Biopharm Stat; 2001 Nov; 11(4):335-46. PubMed ID: 12018783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Confidence-interval construction for rate ratio in matched-pair studies with incomplete data.
    Li HQ; Chan IS; Tang ML; Tian GL; Tang NS
    J Biopharm Stat; 2014; 24(3):546-68. PubMed ID: 24697611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A theoretical evaluation of linearity.
    Kroll MH; Emancipator K
    Clin Chem; 1993 Mar; 39(3):405-13. PubMed ID: 8448849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and analysis of method equivalence studies.
    Borman PJ; Chatfield MJ; Damjanov I; Jackson P
    Anal Chem; 2009 Dec; 81(24):9849-57. PubMed ID: 19925005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Permissible performance limits of regression analyses in method comparisons.
    Haeckel R; Wosniok W; Al Shareef N
    Clin Chem Lab Med; 2011 Nov; 49(11):1805-16. PubMed ID: 21815870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two-sided tolerance intervals for balanced and unbalanced random effects models.
    Hoffman D; Kringle R
    J Biopharm Stat; 2005; 15(2):283-93. PubMed ID: 15796296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generalized confidence intervals for ratios of regression coefficients with applications to bioassays.
    Bebu I; Seillier-Moiseiwitsch F; Mathew T
    Biom J; 2009 Dec; 51(6):1047-58. PubMed ID: 19894218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing equivalence of two assays using sensitivity and specificity.
    Quiroz J; Burdick RK
    J Biopharm Stat; 2007; 17(3):433-43. PubMed ID: 17479392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PCMO L01-Setting Specifications for Biological Investigational Medicinal Products.
    Krause SO
    PDA J Pharm Sci Technol; 2015; 69(5):569-89. PubMed ID: 26429107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonparametric equivalence testing with respect to the median difference.
    Meier U
    Pharm Stat; 2010; 9(2):142-50. PubMed ID: 19565562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precision of the reportable value-Statistical optimization of the number of replicates.
    Burdick RK; Ermer J
    J Pharm Biomed Anal; 2019 Jan; 162():149-157. PubMed ID: 30240988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.